hrp0098p3-314 | Late Breaking | ESPE2024

MRI Structural and Functional Changes in Children with Growth Hormone Deficiency: A Chronological Review

Hamed Noor , Soliman Ashraf , Alyafei Fawzia , AlHemedi Noora , Alaaraj Nada , Ahmed Shayma , Elawwa Ahmed , Bedair Elsaid

Introduction: This review aims to chronologically summarize MRI findings in children with GHD, correlating these changes with clinical characteristics and GH testing results, and IGF-1 levels.Methods: We reviewed MRI studies conducted from 1991 to 2024, focusing on structural and functional brain changes in children with GHD. Data were extracted from various studies and arranged chronologically.<st...

hrp0098p3-315 | Late Breaking | ESPE2024

Prevalence and Clinical Associations of Functional Brain Changes in Children with Growth Hormone Deficiency: A Comprehensive Review

Soliman Ashraf , Alyafei Fawzia , Alaaraj Nada , Hamed Noor , Ahmed Shayma , AlHemedi Noora , Elawwa Ahmed

This review summarizes the prevalence and degree of functional brain changes detected by fMRI in Growth Hormone Deficiency (GHD) patients and their clinical associations in studies from 2019 to 2024Results: Author Year Prevalence of F...

hrp0098p3-316 | Late Breaking | ESPE2024

Functional Magnetic Resonance Imaging (fMRI) Findings and Brain Maturity Index in Children with Idiopathic Short Stature and Growth Hormone Deficiency: A Comprehensive Review

Soliman Ashraf , Alyafei Fawzia , Alaaraj Nada , Hamed Noor , Ahmed Shayma , AlHemedi Noora , Elawwa Ahmed , Noureldin Abbas

Introduction: Idiopathic short stature (ISS) and growth hormone deficiency (GHD) are conditions that can result in various cognitive and behavioral abnormalities. Functional Magnetic Resonance Imaging (fMRI) is a valuable tool for investigating brain functional connectivity and maturity, offering insights into the neurological underpinnings of ISS and GHD. This review summarizes fMRI findings and their clinical associations, highlighting differences in brain m...

hrp0098p3-317 | Late Breaking | ESPE2024

Genetic Findings in Growth Hormone Deficiency and Idiopathic Short Stature: A Comprehensive Review

Soliman Ashraf , Alyafei Fawzia , Alaaraj Nada , Hamed Noor , Ahmed Shayma , AlHemedi Noora , Elawwa Ahmed

Introduction: This review summarizes the genetic findings in Growth Hormone Deficiency (GHD) versus Idiopathic Short Stature (ISS) and their effects on clinical, radiological, and laboratory outcomes.Methods: A literature review was conducted to identify studies reporting genetic findings related to GHD and ISS.Results: Genetic Findings in GHD: Mutations in GH-1, G...

hrp0098p3-325 | Late Breaking | ESPE2024

Prevalence and Degree of Structural Changes in Children with Growth Hormone Deficiency: A Comparative Review with Idiopathic Short Stature

Soliman Ashraf , Alyafei Fawzia , Alaaraj Nada , Ahmed Shayma , AlHemedi Noora , Elawwa Ahmed

Introduction: This chronological review of MRI studies from 1991 to 2024 ims to summarize the prevalence and degree of MRI-detected structural changes in GHD patients and compare these findings with children having Idiopathic Short Stature (ISS).Methods: Data were extracted from various studies, highlighting key changes and comparisons with ISS.Results: Studies consistently show si...

hrp0095p1-138 | Multisystem Endocrine Disorders | ESPE2022

Long-term Growth and Endocrine Complications of Bone Marrow Transplantation in Children and Adolescents with Beta-Thalassemia Major: Comparison with Conventional treatment

Ahmed Shayma , Soliman Ashraf , Alaaraj Nada , Hamed Noor

Introduction: The conventional approach to the treatment of Beta- thalassemia major (BTM) is based on the correction of hemoglobin status through regular blood transfusions and iron chelation therapy for iron overload. Allogeneic hematopoietic stem cell transplantation (HCT) remains the only currently available technique that has curative potential. No previous study compared the long-term growth and endocrinopathy changes among large cohorts of BTM patients o...

hrp0095p2-100 | Fat, Metabolism and Obesity | ESPE2022

Comparison between Triglyceride-Glucose Index (TyG) and Atherogenic index of plasma (AIP) in relation to the different components of the metabolic syndrome (MetS) in morbidly obese children

Hamed Noor , Soliman Ashraf , Alaaraj Nada , Ahmed Shayma

Background: Metabolic syndrome (MetS) is related to increased cardiovascular complications of obesity. The triglyceride-glucose (TyG) index is frequently used as an indicator of insulin resistance in adults. However, there is scant information on the TyG index in the morbidly obese Pediatric population, nor is its correlation with the components of the metabolic syndrome (MetS).Methods: We compared the use of TyG vs athe...

hrp0095p2-104 | Fat, Metabolism and Obesity | ESPE2022

Leptinemia and cardiometabolic risk factors in genetic obesity syndromic in children : Prader Willi and Bardet Biedl

Touzani Asmae , Drai Jocelyne , Balafrej Amina , Gaouzi Ahmed , Chabraoui Layachi

Obesity is a state of imbalance between food intake and energy expenditure leading to a positive energy balance. This condition may be due to the existence of a genetic syndrome: the Prader-Willi syndrome (PWS) is the genetic cause the most common obesity and Laurence-Moon Bardet-Biedl syndrome (BBS), autosomal recessive.Objectives: Our objective is to compare the cardio-metabolic risk factors in children with obesity gene to those of ch...

hrp0092lb-17 | Late Breaking Posters | ESPE2019

Assessment of Urinary Podocalyxin as a Marker of Glomerular Injury in Obesity Related Kidney Disease in Obese Children and Adolescents compared to urinary Albumin-creatinine ratio

Hassan Mona , Musa Noha , Ramzy Tarek , Hamdy Ahmed

Introduction: Epidemiological data suggest that obesity was associated with increased risk of renal injury in children.Objective: To assess urinary podocalyxin in obese children and adolescents as a marker of obesity related kidney disease (ORKD) compared to urinary albumin creatinine (A/C) ratio as the standard marker of glomerular injury.Methodology: This case-control study inclu...

hrp0092p2-156 | GH and IGFs | ESPE2019

Growth Hormone Monotherapy Versus Combined GH and LHRH Analog in 2 Sisters with Short Stature, Early Pubertal Development, and Advanced Bone Age (BA)

Elsiddig Sohair , Soliman Ashraf , Alaaraj Nada , Khalil Ahmed

Introduction: There is still a debate on the effect of combined treatment with growth hormone (GH) and a luteinizing hormone-releasing hormone (LHRH) analog versus GH alone on final adult height in children with idiopathic short stature (ISS) and those who have early pubertal development at a short height.Case Report: We studied two sisters with a history of familial short stature, early puberty and advanced bone age at ...